PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES - Folgori, A; Barnes, E; Aston, S; Smith, K; Brown, A; Ambrosio, M; Ammendola, V; Bartiromo, M; Capone, S; Naddeo, M; Sparacino, A; Siani, L; et al. (JOURNAL OF HEPATOLOGY, 2009)